JOINT CONGRESS
24th WORLD CONGRESS WSAVA
26th WVA WORLD CONGRESS
5th FECAVA CONGRESS
LYON-FRANCE SEPTEMBER 22-29,1999
Evaluation of a recombinant rabies vaccine local postvaccinal reactions
Dennis W.Macy, DVM, MS; John Chretin, DVM
Veterinary Teaching Hospital, Colorado State University, Fort Collins, USA
Background: An association between the administration of inactivated vaccines (primarily feline leukemia and rabies virus vaccines) and subsequent vaccine site tumor development exists. Inflammation is considered to be a necessary antecedent to tumor production at vaccine sites in cats. All currently available subcutaneously administered rabies vaccines are adjuvanted and produce injection site granulomas. A new nonadjuvanted canarypox rabies vector vaccine has recently been approved for use in cats.
Aims: This study evaluated the injection site reactions of five nonadjuvanted feline vaccine combination products, four of which contained the new canarypox rabies vector fraction in a rodent model that has previously been shown to mimic the local inflammatory response in cats.
Methods: Thirty rats were divided into five groups of six. Each received a sham subcutaneous injection of saline and, on the opposite side, one of five feline vaccine combinations. Group A vaccine contained panleukopenia (P), rhinotracheitis (RH) and calicivirus (C) combination. Group B contained recombinant rabies (RR) with P, and RH fractions. Group C contained RR with P, RH, and C, and a killed nonadjuvanted feline leukemia. Group D contained RR, P, RH, C, Chlamydia (Ch), and a killed nonadjuvanted feline leukemia. Group E contained RR, P, RH, C, and Ch. Twenty-one days postinjection, the skin was tented and the skin fold thickness over the injection sites was measured and tissue was removed for histologic evaluation.
Results: No evidence of granuloma formation was of any of the vaccine groups or saline controls. Histologic evaluation of injections failed to detect any evidence of injection site inflammatory reactions.
Conclusion: If chronic inflammation (granuloma formation) is a necessary antecedent to oncogene activation/tumor suppressor inactivation and subsequent tumor development after vaccination in the cat, these nonadjuvanted nonlocally reactive feline vaccines should be least likely to be associated with injection site sarcoma development.
To return to Sylvia's Cyber Kitty Condo just scratch her banner below........